152 related articles for article (PubMed ID: 9591766)
1. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans.
Conway MA; Bottomley PA; Ouwerkerk R; Radda GK; Rajagopalan B
Circulation; 1998 May; 97(17):1716-23. PubMed ID: 9591766
[TBL] [Abstract][Full Text] [Related]
2. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
3. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy.
Pluim BM; Lamb HJ; Kayser HW; Leujes F; Beyerbacht HP; Zwinderman AH; van der Laarse A; Vliegen HW; de Roos A; van der Wall EE
Circulation; 1998 Feb; 97(7):666-72. PubMed ID: 9495302
[TBL] [Abstract][Full Text] [Related]
4. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
5. Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study.
Palmieri V; Bella JN; Arnett DK; Oberman A; Kitzman DW; Hopkins PN; Rao DC; Roman MJ; Devereux RB;
Am Heart J; 2003 Jun; 145(6):1071-7. PubMed ID: 12796765
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure.
Kono T; Sabbah HN; Rosman H; Alam M; Jafri S; Goldstein S
J Am Coll Cardiol; 1992 Dec; 20(7):1594-8. PubMed ID: 1452934
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation.
Flemming MA; Oral H; Rothman ED; Briesmiester K; Petrusha JA; Starling MR
Am Heart J; 2000 Sep; 140(3):476-82. PubMed ID: 10966551
[TBL] [Abstract][Full Text] [Related]
8. 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human.
Jung WI; Dietze GJ
Am J Cardiol; 1999 Jun; 83(12A):19H-24H. PubMed ID: 10750582
[TBL] [Abstract][Full Text] [Related]
9. Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Kontos J; Papademetriou V; Wachtell K; Palmieri V; Liu JE; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hum Hypertens; 2004 Jun; 18(6):431-6. PubMed ID: 15042117
[TBL] [Abstract][Full Text] [Related]
10. Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency.
Kumpuris AG; Quinones MA; Waggoner AD; Kanon DJ; Nelson JG; Miller RR
Am J Cardiol; 1982 Apr; 49(5):1091-100. PubMed ID: 6461239
[TBL] [Abstract][Full Text] [Related]
11. [31P Magnetic Resonance Spectroscopy in Patients With Various Genesis of Left Ventricular Hypertrophy].
Ternovoy SK; Mazaev VV; Stukalova OV; Serova NS
Kardiologiia; 2015; 55(9):5-9. PubMed ID: 26898088
[TBL] [Abstract][Full Text] [Related]
12. Role of inadequate adaptive left ventricular hypertrophy in the genesis of mitral regurgitation in patients with severe aortic stenosis: implications for its prevention.
Palta S; Gill KS; Pai RG
J Heart Valve Dis; 2003 Sep; 12(5):601-4. PubMed ID: 14565713
[TBL] [Abstract][Full Text] [Related]
13. Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy.
Onorati F; Rubino AS; Marturano D; Pasceri E; Santarpino G; Zinzi S; Mascaro G; Renzulli A
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):654-62. PubMed ID: 19698852
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
15. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.
Lodi R; Rajagopalan B; Blamire AM; Cooper JM; Davies CH; Bradley JL; Styles P; Schapira AH
Cardiovasc Res; 2001 Oct; 52(1):111-9. PubMed ID: 11557239
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography.
Leung DY; Griffin BP; Stewart WJ; Cosgrove DM; Thomas JD; Marwick TH
J Am Coll Cardiol; 1996 Nov; 28(5):1198-205. PubMed ID: 8890816
[TBL] [Abstract][Full Text] [Related]
17. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.
Bakermans AJ; Abdurrachim D; van Nierop BJ; Koeman A; van der Kroon I; Baartscheer A; Schumacher CA; Strijkers GJ; Houten SM; Zuurbier CJ; Nicolay K; Prompers JJ
NMR Biomed; 2015 Oct; 28(10):1218-27. PubMed ID: 26269430
[TBL] [Abstract][Full Text] [Related]
18. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
[TBL] [Abstract][Full Text] [Related]
19. Prediction of postoperative left ventricular pump function in congenital mitral regurgitation.
Murakami T; Nakazawa M; Nakanishi T; Momma K
Pediatr Cardiol; 1999; 20(6):418-21. PubMed ID: 10556388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy.
Tagami T; Sakuma H; Matsumura K; Takeda K; Mori S; Takeuchi T; Nakano T
Invest Radiol; 1998 Mar; 33(3):171-6. PubMed ID: 9525756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
